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Abstract (250 words): reflects objectives and novelty. Include  28 
 Objectives 29 
 Methodology (include species studied and whether one or both sexes were included) 30 
 Key Results 31 
 Major Conclusion 32 
Sulfatides and gangliosides are raft-associated glycolipids essential for maintaining myelinated nerve 33 
integrity. Mice deficient in sulfatide (cerebroside sulfotransferase knockout, CST-/-) or complex 34 
gangliosides (β-1,4-N-acetylegalactosaminyltransferase 1 knockout, GalNAc-T-/-) display prominent 35 
disorganization of protein localisation at the node of Ranvier (NoR) in early life, and age-dependent 36 
neurodegeneration. Loss of neuronal rather than glial complex gangliosides underpins the GalNAc-T-37 
/- phenotype, as shown by neuron or glial-specific rescue whereas sulfatide is only expressed and 38 
functional in glial membranes. The similarities in NoR phenotype of CST-/-, GalNAc-T-/- and axo-glial 39 
protein deficient mice suggests these glycolipids may stabilise membrane proteins including 40 
neurofascin 155 (NF155) and myelin-associated glycoprotein (MAG) at axo-glial junctions. To assess 41 
the functional interactions between sulfatide and gangliosides, CST-/- and GalNAc-T-/- genotypes were 42 
interbred. CST-/-x GalNAc-T-/- mice develop normally to P10, but all die between P20-P25, coinciding 43 
with peak myelination. Ultrastructural, immunohistological and biochemical analysis reveals 44 
widespread axonal degeneration and disruption to the axo-glial junction at the NoR. In the CNS, in 45 
addition to sulfatide-dependent loss of NF155, CST-/-x GalNAc-T-/- mice exhibited a major reduction in 46 
MAG protein levels in myelin, when compared to wild type and single lipid deficient mice. The CST-/-x 47 
GalNAc-T-/- phenotype was fully restored to that of CST-/- mice by neuron-specific expression of 48 
complex gangliosides, but not by glial-specific expression, and not by the global expression of a-series 49 
gangliosides. These data indicate that sulfatide and complex b-series gangliosides on the glial and 50 
neuronal membranes respectively, act in concert to promote NF155 and MAG in maintaining the 51 
stable axo-glial interactions essential for normal nerve function.   52 
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Significance Statement (120 words max) 53 
provide a clear explanation of the importance and relevance of the research in a manner accessible 54 
to researchers without specialized knowledge in the field and informed lay readers. 55 
Sulfatides and complex gangliosides are membrane glycolipids with important roles in maintaining 56 
nervous system integrity. Node of Ranvier maintenance in particular requires stable 57 
compartmentalisation of multiple membrane proteins. The axo-glial adhesion molecules neurofascin 58 
155 and myelin-associated glycoprotein require membrane microdomains containing either sulfatides 59 
or complex gangliosides to localise and function effectively. The co-operative roles of these 60 
microdomains and associated proteins are unknown. Here we show vital interdependent roles for 61 
sulfatides and complex gangliosides as double (but not single) deficiency causes a rapidly lethal 62 
phenotype in early age. These findings suggests that sulfatides and complex gangliosides on opposing 63 
axo-glial membranes are responsible for essential tethering of the axo-glial junction proteins, 64 
neurofascin155 and myelin-associated glycoprotein that interact to maintain the nodal complex. (120 65 
words)  66 
5 
 
Introduction (650 words) 67 
“briefly indicate the objectives of the study and provide enough background information to clarify 68 
why the study was undertaken and what hypotheses were tested” 69 
 70 
Glycosphingolipids are highly enriched in lipid rafts (Simons and Toomre, 2000), involved in the 71 
topographical organisation of membrane proteins (Jackman et al., 2009; Sonnino et al., 2014; 72 
Sonnino et al., 2015). Sulfatide, 3-O-sulfogalactosylceramide,  synthesised from galactocerebroside 73 
(GalC) by cerebroside sulfotransferase enzyme (Figure 1A) is enriched in the outer leaflet of the 74 
myelin membrane (Ishizuka, 1997). Complex ganglioside biosynthesis requires β-1,4-N-75 
acetylegalactosaminyltransferase 1, GalNAc-T enzyme activity (Figure 1A) with ganglioside 76 
expression being widespread in both neuronal and glial membranes. Evidence indicates that both 77 
sulfatide and complex gangliosides are crucial for the maintenance and stability, rather than the 78 
developmental formation of nervous system domains (Takamiya et al., 1996; Honke et al., 2002). 79 
Mice deficient in these lipids thus develop relatively normally, before showing age-dependent 80 
degeneration[c1] (Takamiya et al., 1996; Honke et al., 2002). Evidence in particular indicates that these 81 
glycolipids are essential for stabilising the normal arrangement of axo-glial interactions, specifically 82 
at the paranodal region of the node of Ranvier (NoR). Mice deficient for GalC and sulfatide (Dupree 83 
et al., 1999), sulfatide alone (Ishibashi et al., 2002; Marcus et al., 2006; Hoshi et al., 2007) or complex 84 
gangliosides (Susuki et al., 2007) have prominently disrupted paranodes. The paranode in both the 85 
PNS and CNS  tethers and seals the abutted axon and glial membranes between the node and 86 
juxtaparanode (Garcia-Fresco et al., 2006; Susuki et al., 2013), thereby maintaining nodal voltage-87 
gated sodium (Nav) and juxtaparanodal potassium (Kv) channel clustering and segregation, essential 88 
for normal conduction (Salzer, 1997; Poliak and Peles, 2003). The importance of appropriate 89 
expression and localisation of the paranodal proteins in stabilising Nav channel clusters is also 90 
revealed in paranodal protein knockout mice. Thus deficiency in contactin, contactin-associated 91 
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protein (Caspr) or neurofascin (NF) 155 leads to progressive paranodal defects from P10 and 92 
subsequent axon degeneration, with most mice dying by P21 (Bhat et al., 2001; Boyle et al., 2001; 93 
Pillai et al., 2009). Significantly, while these adhesion complex proteins comprise the physical 94 
adhesion barrier at the paranode, associated glycolipid molecules appear to be required for their 95 
localisation and stabilisation, likely by the targeting and transportation of adhesion molecules in lipid 96 
rafts. In support of this Schafer et al. (2004), showed that sulfatide deficiency disrupted lipid rafts, 97 
leading to the loss of NF155 targeting to the paranode, thereby limiting its co-clustering function 98 
with axo-glial partners. Additionally, extraction studies identified sulfatide-containing lipid rafts as 99 
anchors for the axo-glial adhesion molecule myelin-associated glycoprotein (MAG), as well as NF155 100 
(Pomicter et al., 2013).  101 
Complex gangliosides are also an important lipid raft component required for paranode stabilisation, 102 
as shown by an absence of transverse bands and dissociation of paranodal proteins in GalNAc-T-/- 103 
mice (Susuki et al., 2007). As gangliosides are present in both neuronal and glial membranes, their 104 
principal site of action in paranodal stabilisation cannot be presumed. To address this, we 105 
demonstrated that loss of neuronal complex gangliosides underpins the GalNAc-T-/- phenotype as 106 
selective reintroduction of complex ganglioside expression in neuronal but not glial membranes 107 
rescues the paranodal phenotype (Yao et al., 2014). Complex gangliosides GT1b and GD1a, both 108 
prominently expressed on the axonal membrane, are trans receptors for glial membrane-associated 109 
MAG (indicated in Figure 1A)(Collins et al., 1997; Vinson et al., 2001). Analysis of protein extracts 110 
demonstrated a reduction in MAG levels in GalNAc-T-/- mice (Sheikh et al., 1999; Kawai et al., 2001), 111 
which suggests that complex neuronal gangliosides and glial MAG cooperatively contribute to the 112 
stability of the axo-glial junction.  113 
Importantly, loss of sulfatide does not alter ganglioside content (Honke et al., 2002) and complex 114 
ganglioside deficiency does not alter sulfatide content (Yamashita et al., 2005) which suggests their  115 
expression is not directly inter-linked in a compensatory way, but nevertheless might be additive 116 
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functionally. Herein we considered that as these glycolipids are differentially expressed in glial and 117 
axonal membranes, they may act in partnership to retain clustered proteins in their respective 118 
domains. We sought to test this by interbreeding strains of single null mice and neuronal and glial 119 
specific rescue mice, thereby allowing us to assess interdependency and cooperativity in the role of 120 
axonal and glial glycolipids in paranodal organisation.  121 
  122 
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Methods 123 
 Give sufficient detail to permit repetition of the work by others:  124 
 Reference should be made to published procedures wherever possible; this applies to the 125 
original description and pertinent published modifications. 126 
 The sex of subjects should be stated 127 
 All companies from which materials were obtained should be listed. RRIDS 128 
 If materials were obtained from an individual, an affiliation for that individual should be listed. 129 
 Neurosci requires every research manuscript to include an Experimental Design and 130 
Statistical Analysis section as a subsection of the Materials and Methods that describes the 131 
experimental design and the statistical tests used in the study 132 
 133 
Mice. Seven mouse lines on the C57Bl/6 background were used and generated: 1. Wild type (WT); 2. 134 
GalNAc-T-/-; 3. CST-/-; 4. CST-/- x GalNAc-T-/--Tg(neuronal); 5. CST-/- x GD3s-/-; 6. CST-/- x GalNAc-T-/-; 7. 135 
CST-/- x GalNAc-T-/--Tg(glial); (group number and age are described per experiment below). 136 
Generation of GalNAc-T-/- and CST-/- transgenic mice has previously been described (Takamiya et al., 137 
1996; Honke et al., 2002) and were interbred to produce the CST-/- x GalNAc-T-/- genotype. Double 138 
null mice with reconstituted site-specific expression of complex gangliosides were produced by 139 
crossing the CST-/- genotype with previously described GalNAc-T-/--Tg(neuronal) or GalNAc-T-/--140 
Tg(glial) strains (Yao et al., 2014) or GD3s-/- (Okada et al., 2002) resulting in CST-/- x GalNAc-T-/--141 
Tg(neuronal), CST-/- x GalNAc-T-/--Tg(glial) and CST-/- x GD3s-/-, respectively. CST-/- x GalNAc-T-/--142 
Tg(glial) bred poorly and there were insufficient numbers to fully phenotype; therefore their 143 
inclusion was restricted to survival data and phenotypic analysis. Mice were maintained under a 12 144 
hour light/dark cycle in controlled temperature and humidity with unlimited access to food and 145 
water. For each study, mMice of either sex [m2]were killed by rising CO2 inhalation; all experiments using 146 
mice were performed in accordance with a licence approved and granted by the United Kingdom 147 
Home Office and conformed to University of Glasgow institutional guidelines. Experiments complied 148 
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with relevant guidelines on the care and use of animals outlined in the revised Animals (Scientific 149 
Procedures) Act 1986. 150 
 151 
Phenotypic analysis of mice. Weights were obtained at P22 from wild type (n=5), GalNAc-T-/- (n=5), 152 
CST-/- (n=4), CST-/- x GalNAc-T-/--Tg(neuronal) (n=4), CST-/- x GD3s-/- (n=6) and  CST-/- x GalNAc-T-/- 153 
(n=10) mice. Data points from every animal per genotype were plotted, and the mean and S.E.M 154 
displayed. Survival plots for all genotypes were plotted over 200 days for each genotype: wild type 155 
(n=7); GalNAc-T-/- (n=10); CST-/- (n=18); CST-/- x GalNAc-T-/--Tg(neuronal) (n=6); CST-/- x GD3s-/- (n=38), 156 
CST-/- x GalNAc-T-/--Tg(glial) mice (n=12); and  CST-/- x GalNAc-T-/- (n=29). Mice were photographed 157 
when suspended by the tail to record hind-limb leg splaying (a feature of many neurodegenerative 158 
mutants), and gross brain anatomy was also recorded upon brain removal at P22. 159 
 160 
Materials. Monoclonal antibodies used to detect complex a- or b-series gangliosides by 161 
immunofluorescent staining were generated and described previously (Bowes et al., 2002; Boffey et 162 
al., 2005). Anti-GM1 ganglioside antibody, DG2, and anti-GD1b antibody, MOG1, were used at 20 163 
µg/ml. A new monoclonal anti-sulfatide antibody, GAMEG3, derived from mice inoculated with 164 
sulfatide-bearing liposomes was used to detect sulfatide (Meehan et al., in press).  Primary 165 
antibodies were used as follows: mouse anti-phosphorylated neurofilament-H antibody (NF-H, 166 
BioLegend; RRID:AB_2715851; 1:2000); rat anti-MBP (BioRad; RRID:AB_325004; 1:500); mouse anti-167 
pan Nav (Sigma; RRID:AB_477552; 1:100); mouse anti-ankyrin G (ThermoFisher scientific; 168 
RRID:AB_2533145; 1:100); rabbit anti-Caspr (gifted from Professor Peles, Weizmann Institute, Israel; 169 
1:1500); rabbit anti-Kv1.1 (Alomone labs; RRID:AB_2040144; 1:200); rabbit anti-Nav1.6 (Sigma; 170 
RRID:AB_477480; 1:100); rabbit anti-pan neurofascin (gifted from Professor Brophy, University of 171 
Edinburgh, UK; pNFasc 1:1000); mouse anti-MAG antibody (gifted from Professor Brophy, University 172 
of Edinburgh, UK; 1:100). Primary antibodies used in Western blots were rabbit anti-MAG 248 (gifted 173 
from Prof. N Groome, 1:10000[m3])(Barrie et al., 2010) and rabbit anti-NF155 (gifted from Professor 174 
10 
 
Brophy, University of Edinburgh, UK; 1:5000) were prepared in 5% semi-skimmed milk in TBS 175 
containing 0.1% Tween-20 (T-TBS). Secondary antibodies were made in PBS plus 1% NGS: isotype-176 
specific (IgG1, IgG3) Alexa Fluor 488- and 555-conjugated goat anti-mouse IgG antibodies (Molecular 177 
Probes; RRID:AB_141780); Alexa Fluor 488- and 555-conjugated goat anti-rabbit (Molecular Probes; 178 
RRID:AB_141761) and anti-rat IgG antibodies (Molecular Probes; RRID:AB_141733). Secondary 179 
antibody for western blots was HRP-linked goat anti-rabbit (Dako, 1:10 000) prepared in 5% 180 
skimmed milk/T-TBS. 181 
 182 
Immunostaining , Image acquisition and analysis.   183 
Lipid localisation: Snap-frozen peripheral nerves were transversely sectioned at 10µm and collected 184 
onto APES-coated slides (n=3/genotype). Sections were treated with 100% EtOH for 10 min at -20C 185 
then thoroughly washed in PBS. Antibodies were applied to the sections overnight at 4C in the 186 
following combinations: 1) anti-ganglioside antibody DG2 or MOG1 with anti-phosphorylated NF-H 187 
antibody; 2) anti-sulfatide antibody with anti-MBP antibody. Sections were PBS washed secondary 188 
antibodies applied for 1h at R.T. Slides PBS washed and mounted in citifluor. Representative images 189 
were captured at 40x magnification using a Zeiss AxioImager Z1 with ApoTome attachment and 190 
processed using Zeiss Zen 2 blue edition software. 191 
Nodal protein immunostaining: Sciatic nerves (SN) and optic nerves (OpN) were fixed for 30 min in 192 
4% PFA upon removal from P22 mice (n=3/4 per genotype). Subsequently nerves were 193 
cryoprotected in 30% sucrose, and either gently teased into single fibres (SN) collected on slides, or 194 
frozen in OCT mounting medium and longitudinally sectioned at 10 µm (OpN). To study nodal 195 
protein localization, teased SN were immunostained with primary antibodies for either anti- Nav1.6, 196 
anti-Kv1.1 or pNFasc, and OpN sections were immunostained with primary antibodies for 197 
combinations of anti- pNav and anti-pNFasc, or anti-Caspr and anti-AnkG. OpN sections and unfixed 198 
peripheral nerve sections were stained with anti- MAG antibody. Nerves were pre-treated with 199 
blocking solution (10% normal goat serum + 0.3 % Triton X-100) for 1 h at 4C before incubation 200 
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overnight in the same solution plus primary antibody combinations at the same temperature. Triton 201 
was omitted from blocking and incubation solutions when using unfixed peripheral nerve sections. 202 
Samples were washed 3x 5 min then incubated for 2 h at room temperature in secondary antibody 203 
solution. Slides were coverslipped [c4]in citifluor mount medium after three further 5 min PBS washes. 204 
All nodal protein images were captured at 63x magnification, and MAG immunostained tissue at 40x 205 
magnification using a Zeiss AxioImager Z1 with ApoTome attachment and processed with Zeiss Zen 2 206 
blue edition software. For teased sciatic nerves, 20 NoR on average were imaged and quantified per 207 
mouse for each stain. For optic nerve double-staining combinations, three 10 µm thick z-stacks (30 208 
slices, step value 0.34 µm) were captured per mouse. Four 50 x 50 µm fields of view (FOV) per stack 209 
were analysed for either pNav channel cluster number, number of Nav channel clusters flanked by 210 
intact NFasc dimers, or intact Caspr dimers, using NIH ImageJ software (RRID:SCR_003070). 211 
Clusters/dimers were included in the count if they overlaid the top and right-side borders of the 212 
FOV, and excluded when they overlaid the left-side or lower borders. For MAG staining intensity 213 
analysis, single slices were captured at set exposures from 3 slides per genotype. Graphs + S.E.M or 214 
box-and-whisker plots were used to display the spread of all data points collected from each animal 215 
then means were calculated per genotype for statistical analysis.  216 
 217 
Ultrastructure. Mice (WT n=5,  GalNAc-T-/- n=6, CST-/- n=6,  CST-/- x GalNAc-T-/--Tg(neuronal) n=6, CST-218 
/- x GD3s-/-n=6, CST-/- x GalNAc-T-/- n=5) were transcardially perfused at P25 with 5% 219 
glutaraldehyde/4% paraformaldehyde mixture before the optic nerve was removed and processed 220 
for resin embedding, as previously described (Griffiths et al., 1981). Sections were cut for both light 221 
and ultrastructural analysis. Electron micrographs from transverse sections of the optic nerve at 222 
6700x magnification, were captured on a Jeol CX-100 Electron microscope. For quantification, a 223 
minimum of 10 electron micrographs per animal were taken of randomly selected fields. All 224 
measurements were made on scanned images using NIH ImageJ software. For axon morphometry 225 
and quantification of axonal changes, all axons within or touching the top and left borders of an area 226 
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of interest (AOI) were counted. The axon density and number of degenerating axons within the AOI 227 
were counted. Averaged values from every animal per genotype was plotted, and the mean and 228 
S.E.M displayed. 229 
 230 
Extracellular recordings.  231 
Perineural recordings were made from triangularis sterni nerve-muscle preparations set up as 232 
previously described (Braga et al., 1991; McGonigal et al., 2010). Recordings were made from small 233 
nerve bundles from each genotype (WT n=5,  GalNAc-T-/- n=2, CST-/- n=3,  CST-/- x GalNAc-T-/- n=2). 234 
Perineural Nav and Kv channel waveforms were collected during a paired pulse stimulation protocol. 235 
A representative graph plotting the peak Nav and Kv values as a percentage of the baseline 236 
waveforms at each interstimulus interval (ISI) was used to convey recovery of the nodal ion channel 237 
currents. A two-way ANOVA was used to compare the difference between genotypes, and post-hoc 238 
multiple comparisons to measure differences at each ISI.  239 
Conduction velocity was measured in sciatic nerve (WT n=3,  GalNAc-T-/- n=4, CST-/- n=4,  CST-/- x 240 
GalNAc-T-/- n=5), as previously described (McGonigal et al., 2010). Optic nerves (between the eyeball 241 
and the optic chiasm) were quickly removed into oxygenated (95% O2 and 5% CO2) physiological 242 
Ringer’s solution containing (mM): NaCl, 129; KCl, 3; NaH2PO4, 1.2; CaCl2, 2.4; MgSO4, 1.3; HEPES, 243 
3; NaHCO3, 20; and glucose, 10. The nerves were mounted in a recording chamber and each end 244 
drawn into suction electrodes for electrophysiological studies (WT n=4,  GalNAc-T-/- n=4, CST-/- n=4,  245 
CST-/- x GalNAc-T-/--Tg(neuronal) n=3, CST-/- x GD3s-/-n=6, CST-/- x GalNAc-T-/- n=3). Compound action 246 
potentials were evoked by a supramaximal stimulus (Grass S88 stimulator), applied via a suction 247 
electrode at the proximal cut end, and recorded from a second suction electrode at the distal cut 248 
end. Signals were amplified (CED1902), digitized (NIDAQ-MX A/D converter, National Instruments, 249 
Austin, TX, USA) and analysed using WinWCP version 4.1.0 (J. Dempster, Strathclyde University, 250 
RRID:SCR_014713). Nerves were crushed to confirm the waveforms were real  at the end of the 251 
experiment in order to identify and exclude electrical artefacts from the analysis. Nerve conduction 252 
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velocity was calculated by dividing the length of the nerve by latency (the time between the 253 
stimulation artefact and the highest peak of compound action potential). Average values from every 254 
animal per genotype were plotted, and the mean and S.E.M displayed. 255 
 256 
Western blot. Mouse brains were removed (n=4/genotype), snap frozen in liquid nitrogen, and 257 
stored at -80°C until required. Myelin preparation was conducted using a modification of the 258 
method by Norton and Poduslo (1973). Briefly, brains were homogenised in a buffer composed of 259 
0.85 M sucrose, 10 mM Hepes, pH 7.4, 2 mM DTT, and 1 mM TLCK for 20 sec using an Ultra-Turrax 260 
T8 blender ( IKA-Works Inc., Wilmington, NC) set at maximum speed and 0.25 M sucrose gently 261 
layered on top of the homogenate and then centrifuged at 70,000g for 90 min at 4°C. The myelin 262 
interface was collected, hypotonically lysed in chilled dH2O and pelleted at 23,000g for 30 min at 263 
4°C. Following an additional two rounds of hypotonic lysis, the myelin pellet was resuspended in 10 264 
mM Hepes, pH 7.4, containing 1x protease inhibitor cocktail (Sigma). The myelin fraction was stored 265 
at -80°C until required. The protein concentration was determined using a bicinchoninic acid method 266 
employing BSA as a standard (Pierce, Thermo Scientific). SDS-PAGE/ Western blot analysis was 267 
conducted as previously described (Yool et al., 2001). In brief, 1 and 5 ug of myelin was denatured in 268 
Laemmli buffer, separated on a 4-12%  gel (Biorad), and transferred to nitrocellulose membrane 269 
(Invitrogen). The membrane was blocked with 5% skimmed milk in TBS containing 0.1% Tween-20 (T-270 
TBS) for 1hr at room temperature, then incubated in primary antibodies overnight at 4°C on an 271 
orbital shaker . Following three 10 min washes in T-TBS, the immunocomplex was detected with the 272 
HRP-linked secondary antibody (Dako) and visualised using the ECL reaction as per manufacturer’s 273 
instructions (Pierce, Thermo Scientific). Densitometric analysis of the Western blots was performed 274 
using Image J software (NIH). Average values from every animal per genotype were plotted, and the 275 
mean and S.E.M displayed.  276 
 277 
14 
 
Experimental design and statistical analysis. The number of independent animals are described in 278 
the Methods and Results sections and indicated in figure legends. Statistical differences among 279 
genotypes were determined by one-way or two-way ANOVA followed by a Fisher’s or Tukey’s post-280 
hoc tests using GraphPad Prism 6 software (RRID:SCR_002798). Differences were considered 281 
significant whenat p < 0.05.  282 
 283 
 284 
  285 
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Results 286 
 287 
 present the experimental findings, clearly and succinctly. Only results essential to establish 288 
the main points of the work should be included. Experimental conclusions should normally 289 
be based on an adequate number of observations with statistical analysis of variance and 290 
the significance of differences. 291 
 Authors must provide detailed information for each statistical test applied including: the type 292 
of test; specific p values (not > or < ); degrees of freedom; population size; definition of 293 
population (e.g., number of individual measurements, number of animals of each sex, 294 
number of slices, number of times treatment was applied, etc.); and if performed, what 295 
correction was used to adjust for multiple pairwise comparisons 296 
 JNeurosci requires every research manuscript to report in full the complete results of the 297 
statistical analyses, including degrees of freedom and any estimates of effects size, should 298 
be reported in the Results section. Report exact p values rather than ranges (e.g. p = 0.026 299 
rather than p < 0.05). There are many types of analyses that can be reported, but examples 300 
include F values (F(1, 72) = 14.5, p = 0.003, ANOVA), t values (t(10) = 2.98, p = 0.043, 301 
paired t-test) 302 
 303 
 304 
Ganglioside and sulfatide expression is successfully eliminated in CST-/- x GalNAc-T-/- mice 305 
To investigate the interaction between ganglioside and sulfatide lipids on nervous system integrity, 306 
we studied six transgenic mouse lines: wild type; GalNAc-T-/-; CST-/-; CST-/- x GalNAc-T-/--Tg(neuronal); 307 
CST-/- x GD3s-/-; and CST-/- x GalNAc-T-/-. Table 1 provides an overview of the specific glycolipid 308 
expression and deficiency profiles among the mice generated for this study. We confirmed the 309 
presence of targeted gene disruption and reintroduction in these transgenic lines by PCR and 310 
screening for complex ganglioside or sulfatide expression in neural tissue by immunostaining 311 
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(FIGURE 1). An additional line, CST-/- x GalNAc-T-/--Tg(glial) was subsequently generated for 312 
comparative survival plots. 313 
The CST, GalNAc-T and GD3s genes are disrupted by an insert, which was assessed by PCR. From the 314 
gels in Figure 1B, the larger band represents successful GalNAc-T gene disruption in GalNAc-T-/-, CST-315 
/- x GalNAc-T-/--Tg(neuronal) mice and CST-/- x GalNAc-T-/- mice, and CST disruption in CST-/-, CST-/- x 316 
GalNAc-T-/--Tg(neuronal) mice, CST-/- x GD3s-/-  and CST-/- x GalNAc-T-/- mice. The smaller band 317 
confirms GD3 synthase (GD3s) gene disruption in CST-/- x GD3s-/- mice. Additionally, a band 318 
identifying the GalNAc-T-flag [m5]in the CST-/- x GalNAc-T-/--Tg(neuronal) mouse strain confirms selective 319 
GalNAc-T gene re-expression neuronally. 320 
Confirmation of Aabsence or selective expression of lipids was assessed in all genotypes by staining 321 
peripheral[m6] nerves with two anti-ganglioside antibodies that detected either the a- or b-series 322 
complex gangliosides, and an anti-sulfatide antibody. Qualitative results for immunostaining with 323 
these antibodies in the peripheral nerve are shown in  (FIGURE 1C). As expected, neural tissue from 324 
all genotypes except GalNAc-T-/- mice and CST-/- x GalNAc-T-/- mice was positive for anti-GM1 (a-325 
series) antibody immunolabeling. Additionally, anti-GD1b antibody (b-series) binding was 326 
undetectable in the latter two genotypes confirming absence of all a- and b-series gangliosides. 327 
Similarly, nerves from CST-/- x GD3s-/- mice, null for b-series ganglioside expression, had no 328 
observable immunolabelling with the anti-GD1b antibody. Both a- and b-series gangliosides were 329 
successfully reintroduced in the axons of the CST-/- x GalNAc-T-/--Tg(neuronal) mouse line as shown 330 
by positive anti-GM1 and anti-GD1b immunoreactivity. When neural tissue was immunostained with 331 
anti-sulfatide antibody, positively labelled myelin was observed in wild type and GalNAc-T-/- mice 332 
nerves, while no labelling was detected in the other four genotypes, confirming the absence of 333 
sulfatide expression with CST gene knock out.  334 
 335 
Ganglioside and sulfatide double null mice have a significantly reduced lifespan 336 
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The complex ganglioside null and sulfatide null mouse strains have an age-dependent degenerative 337 
phenotype that manifest clinically from 4 months and 6 weeks respectively. In contrast to each of 338 
the single glycolipid deficient mice, the CST-/- x GalNAc-T-/- mice exhibited a very severe phenotype 339 
from 2 weeks, lethal by 4 weeks. The mouse appears to develop normally and is similar in size to 340 
wild type and single knock out mice, then subsequently fails to thrive, declining in body weight 341 
beyond P15 and showing a significant reduction in weight at P22 (one-way ANOVA F(5,28) = 18.15, 342 
p<0.0001[c7])(FIGURE 2A[m8]). Single pup rearing through removal of litter-mates on three occasions did 343 
not prolong survival. CST-/- x GalNAc-T-/- mice exhibit a hunched, emaciated appearance, develop a 344 
tremor and display hind-limb leg splaying (FIGURE 2B), a typical characteristic of the single knock out 345 
mice at later stages of life. Despite reduction in weight, macroscopic  brain (FIGURE 2B) and nerve 346 
trunk anatomy[m9][RM10] appear normal.  347 
Survival plots demonstrate that incrementally diminishing ganglioside and sulfatide expression 348 
corresponds with a reduction in life expectancy, measured up to 200 days (FIGURE 2C).Wild type and 349 
GalNAc-T-/- mice have a normal life expectancy up to 200 days. CST-/- x GalNAc-T-/- mice have the 350 
shortest life expectancy of the lines studied, never surviving beyond 4 weeks, with the majority only 351 
surviving to P21-P25. In the absence of sulfatide expression, but with normal ganglioside expression, 352 
CST-/- life expectancy at 200 days more than halves. In mice lacking sulfatide and complex 353 
gangliosides globally but with all complex gangliosides reintroduced specifically into neurons (i.e. the 354 
CST-/- x GalNAc-T-/--Tg(neuronal) mouse), life expectancy is restored to that of sulfatide null mice, 355 
with 60% of mice surviving to at least 200 days. Additionally, weight at P22 is comparable in this 356 
genotype to WT, CST-/- and GalNAc-T-/- mice (FIGURE 2A). In order to determine whether a- or b-357 
series complex ganglioside deficiency was responsible for the severity of the double sulfatide and 358 
complex ganglioside null mouse, we examined mice that expressed a-series gangliosides only and 359 
lacked b-series gangliosides (achieved through crossing sulfatide and b-series null mice). These were 360 
only modestly improved relative to the CST-/- x GalNAc-T-/- phenotype, as shown by the failure to 361 
thrive and significant weight loss at P22. Life expectancy is severely reduced with only 50% survival 362 
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at 4 weeks, and less than 10% mice reaching a maximum of 21 weeks.  To determine the importance 363 
of neuronal relative to glial ganglioside expression, CST-/- x GalNAc-T-/- mice were generated with glial 364 
expression of complex gangliosides, i.e.  CST-/- x GalNAc-T-/--Tg(glial). Unlike the successful rescue of 365 
the lethal phenotype with neuronal complex gangliosides, expression of compelx gangliosides in glial 366 
membranes did not improve CST-/- x GalNAc-T-/- survival. Therefore based on survival data, the 367 
genotypes can be categorised into three subsets: mild (WT, GalNAc-T-/-); moderate (CST-/-, CST-/- x 368 
GalNAc-T-/--Tg(neuronal); and severe (CST-/- x GD3s-/-, CST-/- x GalNAc-T-/- ).  369 
 370 
Loss of both sulfatide and complex gangliosides results in a disruption to CNS nodes of Ranvier  371 
Age-dependent loss of nodal integrity is evident in both single ganglioside and sulfatide null mice 372 
and could potentially contribute to loss of normal ion channel clustering, functional deficits and axon 373 
degeneration. Of the single lipid deficient mice, disrupted nodal integrity is more rapid and 374 
pronounced in the sulfatide null mice, beginning post-myelin development (>1 month). To assess 375 
whether this process was enhanced or accelerated in CST-/- x GalNAc-T-/- mice, we initially assessed 376 
changes in both the PNS [m11](sciatic nerve, internal intercostal nerve) and the CNS (optic nerve, brain) at 377 
P22. When the PNS integrity was examined, We we found that combined sulfatide and complex 378 
ganglioside deficiency did not augment the disorganisation of proteins at the node of Ranvier in the 379 
PNS of the single sulfatide null mice (Figure 3A). Peripheral nerve Nav channel clusters were 380 
lengthened both in CST-/- and CST-/- x GalNAc-T-/- sciatic nerves. Despite ANOVA reaching significance, 381 
post-hoc multiple comparisons showed the Nav channel cluster lengths in the latter genotypes did 382 
not reach significance compared to WT, GalNAc-T-/- or each other (one-way ANOVA, F(3,9)=.5794, 383 
p=0.0491). In both CST-/- and CST-/- x GalNAc-T-/- sciatic nerve nodes of Ranvier immunostaining for 384 
Kv1.1 channel domains, normally located at the juxtaparanodes, invaded the paranodal region, 385 
shown by a shortening in the distance between the staining domains, compared to WT and GalNAc-386 
T-/- nerves (one-way ANOVA, F(3,9), p<0.0001). pNFasc staining did not significantly change between 387 
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genotypes (one-way ANOVA, F(3,9) = 1.157, p= 0.38) suggesting no impairment of NF155 paranodal 388 
clustering in peripheral nerve at P22. Additionally, electrophysiological function did not significantly 389 
worsen in CST-/- x GalNAc-T-/- peripheral nerve compared to single sulfatide deficient nerve based on 390 
paired pulse stimulations and conduction velocity measurements (Figure [c12]3B). We performed 391 
perineural recordings to assess the Nav and Kv channel currents of the internal intercostal nerve that 392 
innervates the TS muscle. The recovery of both peaks after paired pulse stimulation was significantly 393 
different among genotypes (Nav peak: two-way ANOVA, F(3,117) = 10.79, p<0.0001. Kv peak: two-394 
way ANOVA, F(3,117) = 32.24, p<0.0001). Both CST-/- and CST-/- x GalNAc-T-/- peaks were significantly 395 
reduced in the initial interstimulus intervals compared to WT and GalNAc-T-/- preparations, as 396 
indicated on the graphs in Figure 3B. Conduction velocity was slower in GalNAc-T-/-, CST-/- and CST-/- x 397 
GalNAc-T-/- sciatic nerve compared to WT, but only reached significance in CST-/- nerve (one-way 398 
ANOVA, F(3,12) = 3.939, p = 0.036). MAG immunostaining was comparable in peripheral nerves of all 399 
four genotypes (Figure 3C). It is thus unlikely that PNS dysfunction and degeneration would account 400 
for the lethal phenotype in double deficient mice and there was no evidence of further disruption to 401 
the PNS in the double deficient mice compared to the sufatide null mice. As such, we then focussed 402 
our attention on the CNS with additional Tg lines.  403 
When comparing Nav channel clustering in the optic nerve from all genotypes there is a significant 404 
reduction in Nav channel cluster number (one-way ANOVA (F(5,13) = 4.76, p=0.0108). CST-/- x 405 
GalNAc-T-/- mice have fewer Nav channel clusters than all other genotypes, but this reduction only 406 
reached significance when compared to wild type and complex ganglioside deficient mice, which 407 
were not significantly different to each other (FIGURE 4A). Although reduced, the number of Nav 408 
channel clusters is within the normal wild type range when sulfatide is expressed or complex 409 
gangliosides are reintroduced in the neuronal membrane in CST-/- x GalNAc-T-/--Tg(neuronal) mice. 410 
This is not the case when a-series gangliosides are expressed globally on the sulfatide null 411 
background in CST-/- x GD3s-/- mice, which have similar cluster numbers to CST-/- x GalNAc-T-/- mice. 412 
Since cluster number does not explicitly define mature nodes of Ranvier, the number of Nav channel 413 
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clusters flanked laterally by intact paranodal neurofascin dimers were assessed. Earlier reports have 414 
shown that lack of sulfatide attenuates neurofascin 155 localisation to the paranodal region 415 
(Ishibashi et al., 2002; Schafer et al., 2004; Marcus et al., 2006), and indeed we found all four lines 416 
with sulfatide deficiency had significantly fewer neurofascin positive paranodal dimers flanking Nav 417 
channel clusters as early as P22 compared to wild type and GalNAc-T-/- mice (one-way ANOVA 418 
(F5,13) = 21.31, p<0.0001)(FIGURE 4B,C). A pan-neurofascin antibody was used that detects both the 419 
neuronal NF186 and glial NF155 isoforms critical for Nav channel clustering and paranodal axo-glial 420 
junction formation, respectively. We detected no change to NF186 [m13][RM14]presence and observed normal 421 
co-localisation with Nav channel clusters suggesting this isoform is not impacted by ganglioside or 422 
sulfatide lipid expression.  423 
Further analysis showed paranodal Caspr dimers were significantly reduced at P22 in all genotypes, 424 
with the exception of GalNAc-T-/- mice, compared to wild type mice (one-way ANOVA (F(5,14) = 8.8, 425 
p=0.0006) (FIGURE 5). However, significance was greatest when wild type was compared to GalNAc-426 
T-/- x CST-/- and CST-/- x GD3s-/- mice. GalNAc-T-/- x CST-/- mice also showed a significant reduction 427 
compared to CST-/- and CST-/- x GalNAc-T-/--Tg(neuronal) nerves. Expression of neuronal a- and b-428 
series gangliosides improved the feature under examination, but global a-series ganglioside 429 
expression did not.  430 
 431 
Glycolipid deficiency reduces CNS axon integrity and function 432 
Age-dependent degeneration beyond 2 months of age is a feature of the CST-/- and the GalNAc-T-/- 433 
mouse strains. The principal ultrastructural abnormality observed in the current study was early 434 
onset CNS axon degeneration in the CST-/- x GalNAc-T-/- mice. There was a significant increase in 435 
degenerating axons in the optic nerve at P25 with diminishing glycolipid expression (one-way 436 
ANOVA (F(5,27) = 11.51, p<0.0001).  CST-/- x GalNAc-T-/- mice had significantly more degenerate 437 
axons compared to wild type and GalNAc-T-/- nerves, which are comparable (FIGURE 6A). The 438 
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number of degenerate axons in CST-/- mice was very variable and reached significance, albeit a lower 439 
level compared to wild type. Additionally, the number of degenerate axons were fewer than 440 
observed for CST-/- x GalNAc-T-/- optic nerve but this difference did not reach significance. A 441 
protection of axons from degeneration was achieved by reinstatement of both a- and b-series 442 
gangliosides neuronally, leading to a reduction in the number of degenerate axons to within wild 443 
type levels. However, the number of degenerate axons was not improved by expression of global a-444 
series ganglioside expression in the CST-/- x GD3s-/- strain, which were equal to CST-/- x GalNAc-T-/- 445 
levels. Electron micrographs show the normal formation of myelin in large diameter myelinated 446 
fibres fibres, alongside abundant unmyelinated and thinly myelinated fibres undergoing myelin 447 
maturation in all genotypes (FIGURE 6B). As peak myelination is in progress at the time-point 448 
studied, abundant unmyelinated fibres and thin myelin was observed in all genotypes in the electron 449 
micrographs, making it uninformative to undertake a meaningful analysis of myelin formation or 450 
maintenance[m15][RM16]. 451 
To investigate the functional consequence of degenerating axons and nodal structure disturbance, 452 
conduction velocity was recorded from isolated optic nerve at P22 (FIGURE 6C). Conduction velocity 453 
was significantly reduced with diminishing glycolipid expression (one-way ANOVA (F(5,18) = 4.25, 454 
p<0.01), which correlated with the survival plots, nodal and ultrastructural data. There was a 455 
significant reduction in CV did not reach significance between any of the genotypes in post-hoc 456 
analysis. The waveforms becamewere abnormal [c17]in CST-/-, CST-/- x GD3s-/- and CST-/- x GalNAc-T-/- optic 457 
nerves as compared to wild type, and GalNAc-T-/- mouse nerves. CST-/- x GalNAc-T-/- conduction 458 
velocity was reduced compared to CST-/- but this did not reach significancewith broader waveforms 459 
that followed a different peak formation. Once more, tThere was an modest improvement in CST-/- x 460 
GalNAc-T-/--Tg(neuronal) with optic nerve conduction velocity rates reachingwaveform within theto 461 
normal wild type and GalNAc-T-/- range and significantly greater than those rates recorded from CST-462 
/- x GD3s-/- and CST-/- x GalNAc-T-/- optic nerve. Although increased, the difference in CST-/- x GalNAc-463 
T-/--Tg(neuronal)  conduction velocity compared to CST-/- mice did not reach significance appearance.[c18] 464 
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 465 
MAG protein expression in myelin is disrupted in sulfatide and ganglioside double null mice 466 
Sulfatide deficiency has previously been reported to alter expression of key myelin proteins, 467 
prompting us to interrogate the differences in the expression of these proteins in the 6 genotypes 468 
studied. Expression of the major myelin proteins PLP and MBP in the myelin fraction from P22 brain 469 
homogenates did not significantly differ among the six genotypes, with the exception of a mildly 470 
reduced expression in WT mice compared to GalNAc-T-/- genotypes (data not shown). A significant 471 
reduction in MAG protein level was observed in the myelin fraction from CST-/- x GalNAc-T-/- mice 472 
compared to all genotypes, which did not significantly differ from one another (one-way ANOVA 473 
F(5,16) = 7.735, p=0.0007) (Figure 7A). Conversely, MAG expression in whole brain homogenates 474 
and in optic nerve sections was comparably reduced in all genotypes compared to wild type, 475 
suggesting an enhanced loss of appropriate trafficking or site-specific anchoring in [m19]myelin in the CST-476 
/- x GalNAc-T-/- mice (WB: one-way ANOVA F(5,18) = 13.87, p<0.0001; immunostaining [m20][RM21][m22][RM23]one-way 477 
ANOVA F(5,12) = 13.36, p = 0.0001) (Figure 7A & B). This notion is strengthened by the comparable 478 
expression of oligodendrocyte transcription factor 2 (Olig2) among genotypes which indicates 479 
oligodendrocyte number is normal and oligodendrocytes are not lost due to glycolipid deficiency 480 
(one-way ANOVA F(5,12) = 0.41, p = 0.835)(Figure 7A). Myelin NF155 protein levels were 481 
significantly reduced to a comparable level in all genotypes deficient in sulfatide, which corresponds 482 
with our immunostaining data and previous reports (one-way ANOVA F(5,18) = 23.41, p<0.0001) 483 
(Figure 7A). This is replicated in the whole brain extract (data not shown).  484 
  485 
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Discussion (1500 words max) 486 
 487 
 The discussion section should be as concise as possible  488 
 brief statement of the principal findings 489 
 discussion of the validity of the observations 490 
 discussion of the findings in light of other published work dealing with the same or closely 491 
related subjects 492 
 statement of the possible significance of the work 493 
 Extensive discussion of the literature is discouraged 494 
 495 
 496 
Glycosphingolipids including sulfatide and complex gangliosides have a significant role in myelinated 497 
nerve maintenance, but their distinct or interdependent roles and interactions are unclear. The 498 
neurodegenerative consequence of deficiency in either sulfatides or complex ganglioside synthesis 499 
through transgenic manipulation indicates a role for these lipids in maintaining myelin and axonal 500 
integrity, particularly at the node of Ranvier (Takamiya et al., 1996; Sheikh et al., 1999; Honke et al., 501 
2002; Ishibashi et al., 2002; Marcus et al., 2002; Hoshi et al., 2007; Susuki et al., 2007). It was the aim 502 
of this study to investigate their interdependency on interacting membranes in order to add insight 503 
to the role each family of lipids plays in myelinated nerve and nodal stability.  504 
We found that interbreeding sulfatide deficient mice with complex ganglioside deficient mice 505 
resulted in an exaggerated neurodegenerative phenotype and early death compared to single null 506 
mice. Through a combination of ultrastructural, immunohistological, functional, and biochemical 507 
studies, we showed that the combined loss of both groups of lipids resulted in a more severe 508 
outcome than single lipid deficiency (Takamiya et al., 1996; Honke et al., 2002). Diminishing 509 
expression of lipids divided the survival of the seven genotypes produced for this study into three 510 
broad groups: Mild (WT and GalNAc-T-/-); Intermediate (CST-/-, CST-/- x GalNAc-T-/--Tg(neuronal)); 511 
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Severe (CST-/- x GD3s-/-, CST-/- x GalNAc-T-/--Tg(glial), CST-/- x GalNAc-T-/-). We reported a more 512 
pronounced phenotype in the CNS than the PNS and thereby focused much of our analysis on the 513 
CNS. Degenerate axon number increased with diminishing lipid content and conduction became 514 
increasingly impaired; MAG expression in the myelin fraction from brain homogenates was 515 
significantly lower in the CST-/- x GalNAc-T-/- genotype compared to all other genotypes; and Nav 516 
channel cluster number, Caspr dimer number and Nav channels flanked by NF155 dimers decreased 517 
with decreasing lipid expression. Rescuing the neuronal, but not the glial complex ganglioside 518 
expression reversed the lethality observed in the double null mice. Examining the relative 519 
importance of a- and b-series gangliosides we observed only modest improvement occurred with 520 
global a-series ganglioside expression on a sulfatide null background. Collectively, these data 521 
indicate the importance of neuronal b-series gangliosides (e.g. GD1b, GT1b) in maintaining survival in 522 
the co-presence of sulfatide deficiency and indicate interdependency between the functions of these 523 
two groups of lipids. We thus propose that sulfatide and b-series ganglioside lipid domains on 524 
opposing membranes majorly contribute to a co-ordinated axo-glial adhesion and paranodal 525 
organisation, a combined loss of which leads to severe impairment of nerve integrity with a fatal 526 
outcome at an early age. 527 
We have previously highlighted the significance of neuronal complex ganglioside expression to nerve 528 
integrity in the GalNAc-T-/- age-dependent neurodegenerative genotype (Yao et al., 2014). 529 
Considering the impact of neuronal ganglioside expression on survival, combined with the reduction 530 
of MAG in the myelin fraction in double deficient mice, these findings suggest an underlying 531 
mechanism for the lethal phenotype in CST-/- x GalNAc-T-/- mice. The complex gangliosides GD1a and 532 
GT1b are prominently expressed on the axonal membrane and are receptors for MAG (Collins et al., 533 
1997; Vinson et al., 2001). MAG is expressed on the periaxonal membrane of the myelin sheath 534 
(Bartsch et al., 1989; Trapp et al., 1989) and is involved in the continuous axo-glial contact and 535 
bidirectional signalling along the myelinated nerve, particularly at the paranode. MAG null mice form 536 
cis bonds in the myelin membrane that are stabilised by trans interactions with gangliosides in the 537 
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neuronal membrane (Pronker et al., 2016). MAG null mice exhibit delayed maturation of nodes and, 538 
similar to GalNAc-T-/- mice, modest nervous system abnormalities, suggesting a role in myelinated 539 
nerve maintenance rather than development (Montag et al., 1994; Li et al., 1998; Marcus et al., 540 
2002; Pan et al., 2005). Previously it has been shown that MAG levels are reduced in GalNAc-T-/- mice 541 
(Sheikh et al., 1999; Kawai et al., 2001), and when considered with the comparable phenotype 542 
between GalNAc-T-/- and MAG-/- mice suggests complex gangliosides and MAG cooperatively 543 
contribute to the stability of the axo-glial junction[m24][RM25]. Indeed[m26], interbreeding GalNAc-T-/- and MAG-/- 544 
strains did not exacerbate the phenotype of the single null mice, suggesting a complementary and 545 
functional interaction between these molecules (Pan et al., 2005). Conversely, in our study, 546 
combining GalNAc-T-/- and CST-/- strains exacerbates the phenotype suggesting two independent 547 
roles. Notably, MAG acts as a myelin receptor for axonal gangliosides, and is localised to the myelin 548 
membrane by sulfatide rich lipid rafts.  Recent analysis of protein extracts from 4-week old sulfatide 549 
null mouse brains confirmed a progressive reduction in MAG and a significant reduction in NF155 550 
(25% compared to wild type)(Palavicini et al., 2016). Taken together with extraction studies that 551 
identified sulfatide-containing lipid rafts as anchors for MAG and NF155 (Pomicter et al., 2013), it 552 
seems that sulfatide acts as a wide-ranging anchor for multiple myelin and glial membrane proteins. 553 
With the knowledge that MAG and sulfatide modulate axo-glial stability, Marcus et al. (2002) 554 
investigated the significance of both molecules to axo-glial integrity by crossing MAG deficient mice 555 
with GalC/sulfatide double deficient mice, which individually have similar phenotypes. Similar to our 556 
lethal sulfatide and ganglioside double deficiency phenotype, this genetic combination resulted in a 557 
lethal phenotype, with survival up to P22 (Marcus et al., 2002). Again, the NoR appear to develop 558 
normally followed by subsequent generalised impairment of the paranodal axo-glial junction. Unlike 559 
the minimal effect of combined MAG and complex ganglioside disruption, MAG and ceramide 560 
galactosyltransferase (CGT) double deficiency aggravates the phenotype suggesting two non-561 
redundant functions are impaired. This phenotype corresponds to our lethal phenotype, indicating 562 
that a loss of interaction between MAG and gangliosides in a membrane environment devoid of GalC 563 
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and sulfatide is fatal. It is likely that GalC/sulfatide has a role in promoting localisation/anchoring of 564 
MAG and subsequently MAG/ganglioside promote axo-glial integrity. Indeed, we reported a striking 565 
deficiency in MAG in the myelin fraction of our double null mice compared to all other genotypes 566 
owing to the loss of its localising agent, sulfatide, and binding partner, complex gangliosides. 567 
The severe neurodegenerative phenotype of our double lipid deficient mice reflected that of 568 
paranodal protein deficient mice (Tait et al., 2000; Bhat et al., 2001; Boyle et al., 2001; Charles et al., 569 
2002), suggesting an essential role for lipids in paranodal protein maintenance. In the current study 570 
we restricted our investigation of nodal disruption to those proteins related to function (Nav 571 
channels) or previously identified as lipid raft associated (NF155, Caspr)(Sheikh et al., 1999; Schafer 572 
et al., 2004; Susuki et al., 2007; Pomicter et al., 2013) and acknowledge that this was not an 573 
exhaustive study. Adhesion molecules freely diffuse in the axon membrane and accumulate at NoR, 574 
whereas ion channels and components of the cytoskeleton require transport (Zhang et al., 2012). 575 
NF186 is essential for maintenance of the Nav channel clusters at the NoR (Zhang et al., 2012; 576 
Desmazieres et al., 2014; Taylor et al., 2017) and appeared unperturbed in our double null mice. This 577 
aligns with the fact that NF186 is likely not raft-associated (Schafer et al., 2004; Susuki et al., 2007). 578 
Intact The presence of NF186 accounts for the relatively minimal reduction in Na channel clusters 579 
and impairment in conduction observed in CST-/- x GalNAc-T-/- mice. Schafer et al. (2004) proposed 580 
an indirect mechanism of axo-glial junction stabilisation at the paranode whereby glycosphingolipid-581 
rich lipid rafts cluster NF155 that then co-cluster with axonal binding partners Caspr and contactin. 582 
Indeed, we confirmed by immunostaining and western blot that NF155 was disrupted in all 583 
genotypes with sulfatide deficiency. The axonal partner of NF155, Caspr, was also disrupted as had 584 
previously been shown in single ganglioside and sulfatide deficiency (Ishibashi et al., 2002; Susuki et 585 
al., 2007), but to a greater degree when both sets of lipids were absent. Caspr has been associated 586 
with ganglioside-rich lipid rafts on the axonal membrane and in their absence, Caspr is not anchored 587 
(Susuki et al., 2007). Our results that the PNS was less perturbed than CNS likely reflects the greater 588 
stability of the peripheral node of Ranvier, and greater influence that the paranode has on stability 589 
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in the CNS (Rasband and Peles, 2015). However, the combined absence of both NF155 and Caspr 590 
through loss of both sulfatide and gangliosides, respectively, likely intensifies the reduction in Nav 591 
channel clusters and ultimately leads to enhanced nodal instability compared to single lipid null 592 
mice.  593 
 594 
Ganglioside, sulfatide and MAG single deficient mice do not exhibit a severe phenotype, strongly 595 
suggesting redundant functions: overexpression/loss of other lipids (e.g. simple gangliosides, 596 
seminolipid) could, in theory, contribute to the overall phenotype in transgenic mice. Mice that lack 597 
the GD3 synthase (GD3s) enzyme that underlies production of all b-series gangliosides (Figure 1A) 598 
have grossly normal nodal architecture (Okada et al., 2002), demonstrating that there is 599 
compensation in the ganglioside family. It is possible that ganglioside deficient mice have a less 600 
severe phenotype than those lacking sulfatide due to compensation by over-expression of simple 601 
gangliosides, notably GM3 & GD3 whose levels are markedly elevated in the GalNAc-T-/- phenotype 602 
(Susuki et al., 2007). The increased severity of double ganglioside null (GM3 only) mice (Kawai et al., 603 
2001; Inoue et al., 2002; Yamashita et al., 2005) lends support for this theory, however, the nodal 604 
protein organisation has not been characterised. It was therefore an unexpected finding that the 605 
CST-/- x GD3s-/- strain had such a severe phenotype. This could be thus explained by the lack of the b-606 
series ganglioside GT1b interacting with MAG (Vinson et al., 2001).  607 
It is clear from these results that sulfatide and complex gangliosides have crucial and independent 608 
roles in clustering proteins on opposing membranes which is essential to normal axo-glial integrity 609 
and nervous system function. Redundant features can compensate for the loss of one family, but 610 
their simultaneous absence leads to a catastrophic accumulation of axon degeneration, axo-glial 611 
disruption and nodal pathology, culminating in early fatalitydeath.  (1617 words, 117 over)  612 
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Figure legends 613 
 614 
Figure 1. Generation of lipid deficient transgenic mouse lines and confirmation by PCR and 615 
immunostaining. Six mouse lines were used and generated: Wild type; GalNAc-T-/-; CST-/-, CST-/- x 616 
GalNAc-T-/--Tg(neuronal); CST-/- x GD3s-/-; CST-/- x GalNAc-T-/-. A) Sulfatide and ganglioside 617 
biosynthesis pathways (associated gene knock outs are indicated in boxes). Ceramide is the 618 
precursor to sulfatide and gangliosides. The cerebroside sulfotransferase (CST) enzyme is necessary 619 
for the synthesis of sulfatide from galactocerebroside (GalC). The GalNAc-transferase (GalNAc-T) 620 
enzyme is necessary for generation of complex gangliosides and the GD3 synthase (GD3s) enzyme 621 
for specific production of a-series complex ganglioside. Constructs were generated to drive GalNAc-T 622 
expression in neurons of GalNAc-T-/- x CST-/- mice to produce the GalNAc-T-/--Tg(neuronal) mouse 623 
line.  Location of MAG binding site to terminal 2,3 sialic acid is indicated by a red circle. B) PCR 624 
results confirm presence or absence of GalNAc-T, GD3s and CST expression in mouse lines. Large 625 
bands represent the disrupted GalNAc-T and CST gene with insert, while the smaller band represents 626 
the disruption of the GD3s gene. The flag identifies the re-introduction of the GalNAc-T gene into the 627 
neurons. C) Expression of a- and b- series gangliosides and sulfatide was confirmed by staining 628 
peripheral nerves with anti-GM1, anti-GD1b and anti-sulfatide monoclonal antibodies (green), 629 
respectively. Axons and myelin were identified with neurofilament or MBP (red), respectively. Scale 630 
bar = 10 µm. 631 
 632 
Figure 2. Altering the expression of gangliosides and sulfatide in novel transgenic mouse lines effects 633 
survival and phenotype. A) The weight of double null (n=10) and CST-/- x GD3s-/- (n=6) mice is normal 634 
during development, but declines from P15-25 and is significantly reduced compared to other 635 
genotypes at P22. Statistical differences among genotypes were determined by one-way ANOVA 636 
followed by Tukey’s post-hoc tests to compare multiple comparisons, indicated on the graphs as 637 
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follows: *p<0.05; **p<0.01; ***p<0.001. B) CST-/- x GalNAc-T-/- and CST-/- x GD3s-/- mice display a 638 
reduction in stature, hindlimb leg splaying, a hunched appearance and tremor at P22. Gross brain 639 
anatomy does not differ between genotypes. C) Survival plots demonstrate that incrementally 640 
diminishing ganglioside and sulfatide expression corresponds with a reduction in life expectancy up 641 
to 25 weeks. Wild type (n=7) and GalNAc-T-/- (n=10) mice have a normal life expectancy. In the 642 
absence of sulfatide with normal ganglioside expression life expectancy to 25 weeks is more than 643 
halved in CST-/- mice (n=18). Interestingly, in the absence of sulfatide and complex gangliosides with 644 
the reintroduction of complex gangliosides into neurons alone (n=6), life expectancy is improved 645 
with 60% of mice surviving to 25 weeks and beyond. Mice with no sulfatide and a-series gangliosides 646 
expressed globally (n=38) can survive up to 20 weeks. Double ganglioside and sulfatide knock out 647 
mice (n=29) have the worst phenotype, never surviving past 4 weeks and with death occurring at 648 
P21-25. Reintroduction of gangliosides into glial (n=12) does not improve survival.   649 
 650 
Figure 3. The additional loss of complex gangliosides on a sulfatide null background does not 651 
augment disorganisation at the node of Ranvier or electrophysiological function in the peripheral 652 
nervous system. A) There is modest Nav1.6 channel cluster lengthening in both CST-/- and CST-/- x 653 
GalNAc-T-/- teased sciatic nerve that does not reach significance. Invasion of the sciatic nerve 654 
paranode by Kv1.1 channels, shown by a decrease in the gap between positive domains, is 655 
significantly and comparably enhanced in both CST-/- and CST-/- x GalNAc-T-/- mice compared to WT 656 
and GalNAc-T-/- nodes of Ranvier. The length of pan-neurofascin immunostained domains does not 657 
significantly differ among genotypes. Representative images are shown of sciatic nerve sections from 658 
each genotype immunostained for Nav1.6 or anti-Kv1.1 antibody. Nav channel clusters were 659 
observed and appeared similar in every genotype. Kv1.1 formed two distinct domains of 660 
immunostaining at the juxtaparanodes in WT and GalNAcT-/- mice. Conversely, mice lacking sulfatide 661 
expression had Kv1.1 staining at the paranodes, suggesting disruption to the axo-glial junction. (WT 662 
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n=3,  GalNAc-T-/- n=3, CST-/- n=3,  CST-/- x GalNAc-T-/- n=4 Scale bar = 5 µm. B) Perineural recordings of 663 
Nav and Kv channel currents from intercostal nerves showed an increase in recovery time for both 664 
peaks following paired pulse stimulation in both CST-/- and CST-/- x GalNAc-T-/- mice compared to WT 665 
and GalNAc-T-/- mice. The CST-/- and CST-/- x GalNAc-T-/- mice were not significantly different from 666 
each other at any interstimulus interval. Graphs display the means and +SEM for each genotype (WT 667 
n=5,  GalNAc-T-/- n=2, CST-/- n=3,  CST-/- x GalNAc-T-/- n=2), and statistical analysis performed (two-668 
way ANOVA; # signifies WT vs. CST-/- x GalNAc-T-/- mice; * signifies WT vs CST-/-; + signifies GalNAc-T-/- 669 
vs CST-/- x GalNAc-T-/-; ^ signifies GalNAc-T-/- vs CST-/- x GalNAc-T-/-). Sciatic nerve conduction velocity 670 
decreased in CST-/-(n=4), GalNAc-T-/- (n=4) and CST-/- x GalNAc-T-/- (n=5) mice compared to wild type 671 
(n=3), but only reached significance in CST-/- nerve. C) Peripheral nerve MAG immunostaining was 672 
comparable among genotypes. Scale bar = 20 µm. Graphs display the means and +SEM for each 673 
genotype, ), and statistical analysis performed (one-way ANOVA followed by Tukey’s post-hoc tests 674 
to compare multiple comparisons, indicated on the graphs as follows: *p<0.05; **p<0.01; 675 
***p<0.001). 676 
 677 
Figure 4. Loss of both sulfatide and complex gangliosides results in a modest reduction in CNS Nav 678 
channel cluster number and sulfatide deficiency reduces NF155 presence at parnodal loops. A) The 679 
number of Nav channel clusters significantly decreases in glycolipid deficient mouse optic nerves 680 
(n=3-4/genotype). Reintroducing a- and b-series gangliosides into neurons rescues this feature. B) 681 
Nav channel clusters flanked by normal paranodal neurofascin are significantly reduced in number 682 
when sulfatide is not expressed (n=2-3/genotype). Box-and whisker plots are used to display the 683 
spread of all data points collected from each animal then means were calculated per genotype for 684 
statistical analysis (one-way ANOVA followed by Tukey’s post-hoc tests to compare multiple 685 
comparisons, indicated on the graphs as follows: *p<0.05; **p<0.01; ***p<0.001). C) Representative 686 
images of optic nerve sections from each genotype double-immunostained for pan-voltage gated 687 
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sodium channel (pNav) antibody (green) and pan-neurofascin (pNFasc) antibody (red). Na channel 688 
clusters were observed in every genotype. pNFasc immunostaining formed a long band crossing the 689 
node and paranodes in WT and GalNAc-T-/- mice suggesting labelling of the NF186 and NF155 690 
isoforms, respectively. All of the genotypes lacking sulfatide expression had pNFasc staining 691 
restricted to the node of Ranvier and co-localising only with pNav staining, suggesting presence of 692 
only the NF186 isoform of neurofascin. Scale bar = 5 µm. 693 
 694 
Figure 5. Paranodal Caspr dimer immunostaining in CNS tissue is progressively reduced with 695 
increasing glycolipid deficiency. A) CST-/- x GalNAc-T-/- and CST-/- x GD3s-/- mice have significantly 696 
fewer Caspr dimers per field of view (FOV) compared to WT and GalNAc-T-/- mice, and are not 697 
significantly different to each other (n=2-5/genotype). Caspr dimer number is improved to levels 698 
within GalNAc-T-/- mice range, but not WT, in CST-/- and CST-/- x GalNAc-T-/--Tg(neuronal) mice, which 699 
both display significantly more Caspr dimers than CST-/- x GalNAc-T-/-  mice. Box-and whisker plots 700 
are used to display the spread of all data points collected from each animal then means were 701 
calculated per genotype for statistical analysis (one-way ANOVA followed by Tukey’s post-hoc tests 702 
to compare multiple comparisons, indicated on the graphs as follows: *p<0.05; **p<0.01; 703 
***p<0.001).  B) Representative images of optic nerve sections from each genotype double-704 
immunostained for Caspr (red) and nodal marker AnkyrinG (green) show the reduction in Caspr 705 
dimer number with diminishing glycolipid expression. Scale bar = 10 µm. 706 
 707 
Figure 6. Glycolipid deficiency reduces CNS axon survival and function. A) Degenerate axon number 708 
increases to a significant level compared to wild type in optic nerves from CST-/-, CST-/- x GD3s-/- and 709 
CST-/- x GalNAc-T-/- mice. Reintroducing a- and b-series gangliosides into neurons rescues this 710 
pathology. B) Electron micrographs depict the differences among the genotypes: white arrowheads 711 
indicate degenerate axons. Myelin is similar among mouse lines. One-way ANOVA followed by 712 
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Tukey’s post-hoc tests to compare multiple comparisons, indicated on the graphs as follows: 713 
*p<0.05; **p<0.01; ***p<0.001. Scale bar = 2 µm C) A reduction in conduction velocity was observed 714 
in optic nerves with diminishing glycolipid content. Representative CAP traces from each genotype 715 
show the normal waveform in WT, GalNAc-T-/- and CST-/- x GalNAc-T-/--Tg(neuronal) optic nerves, 716 
however the waveform becomes abnormal in the CST-/-, CST-/- x GD3s-/- and CST-/- x GalNAc-T-/- mice. 717 
Horizontal scale bar = 2 ms, vertical scale bar = 1 mV.  718 
 719 
Figure 7. N.B. New order of genotypes. MAG and NF155 expression in the myelin fraction is altered 720 
by glycolipid deficiency. A) In the myelin fraction from P22 brain homogenates, MAG is significantly 721 
reduced in CST-/- x GalNAc-T-/- mice compared to all genotypes, which do not significantly differ from 722 
one another (upper graph). All genotypes have a significant reduction in MAG expression in whole 723 
brain homogenate compared to WT (middle graph). Myelin NF155 was significantly reduced in all 724 
genotypes compared to WT (indicated by *) and GalNAc-T-/- (indicated by #), which had similar levels 725 
(lower graph). ^indicates significant difference between CST-/- x GalNAc-T-/- and CST-/- x GalNAc-T-/--726 
Tg(neuronal) mice. Olig2 is unchanged by altered glycolipid expression. Representative blots show 727 
protein intensity per genotype, indicated by the corresponding number indicated in the key. B) P22 728 
optic nerve MAG immunostaining is significantly reduced in all genotypes compared to wild type 729 
nerve, which do not significantly differ from one another. Representative images show MAG 730 
immunostaining per genotype. Means were calculated per genotype for statistical analysis (one-way 731 
ANOVA followed by Tukey’s post-hoc tests to compare multiple comparisons, indicated on the 732 
graphs as follows: *p<0.05; **p<0.01; ***p<0.001). Scale bar = 50 µm.  733 
 734 
Figure 8. Schematic depicting the glycolipid rafts and their associated paranodal proteins Caspr, 735 
NF155 and MAG under wild type conditions and in our transgenic mouse lines. GD1a and GT1b are 736 
represented in the ganglioside rafts as they are the major ligands of MAG, however, in reality the 737 
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rafts would contain all complex gangliosides. Normally GD1a and GT1b in rafts will tether MAG but in 738 
their absence MAG does not make the axo-glial connection. If NF155 is present, this protein can 739 
partner with Caspr/Contactin to make an axo-glial junction. However, when sulfatide is absent, 740 
NF155 is also lost from the paranode.  In the absence of NF155, Caspr presence is also diminished, 741 
especially with loss of complex ganglioside rafts. Under conditions of both ganglioside and sulfatide 742 
raft deficiency, we propose an absence of the structurally supporting proteins MAG and NF155 that 743 
results in the loss of a functionally competent axo-glial junction. 744 
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Table 1. Lipid expression profiles of genotypes in this study.
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Figure 1. Generation of lipid deficient transgenic mouse lines and confirmation by PCR and immunostaining. Six mouse lines 
were used and generated: Wild type; GalNAc-T-/-; CST-/-, CST-/- x GalNAc-T-/--Tg(neuronal); CST-/- x GD3s-/-; CST-/- x GalNAc-T-/-. A) 
Sulfatide and ganglioside biosynthesis pathways (associated gene knock outs are indicated in boxes). Ceramide is the precursor 
to sulfatide and gangliosides. The cerebroside sulfotransferase (CST) enzyme is necessary for the synthesis of sulfatide from 
galactocerebroside (GalC). The GalNAc-transferase (GalNAc-T) enzyme is necessary for generation of complex gangliosides and 
the GD3 synthase (GD3s) enzyme for specific production of a-series complex ganglioside. Constructs were generated to drive 
GalNAc-T expression in neurons of GalNAc-T-/- x CST-/- mice to produce the GalNAc-T-/--Tg(neuronal) mouse line.  B) PCR results 
confirm presence or absence of GalNAc-T, GD3s and CST expression in mouse lines. Large bands represent the disrupted 
GalNAc-T and CST gene with insert, while the smaller band represents the disruption of the GD3s gene. The flag identifies the re-
introduction of the GalNAc-T gene into the neurons. C) Expression of a- and b- series gangliosides and sulfatide was confirmed 
by staining peripheral nerves with anti-GM1, anti-GD1b and anti-sulfatide monoclonal antibodies (green), respectively. Axons 
and myelin were identified with neurofilament or MBP (red), respectively. Scale bar = 10 µm.
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Figure 2. Altering the expression of gangliosides and sulfatide in novel transgenic mouse lines effects survival and phenotype. A) 
The weight of double null (n=10) and CST-/- x GD3s-/- (n=6) mice is normal during development, but declines from P15-25 and is 
significantly reduced compared to other genotypes at P22. Statistical differences among genotypes were determined by one-
way ANOVA followed by Tukey’s post-hoc tests to compare multiple comparisons, indicated on the graphs as follows: *p<0.05; 
**p<0.01; ***p<0.001. B) CST-/- x GalNAc-T-/- and CST-/- x GD3s-/- mice display a reduction in stature, hindlimb leg splaying, a 
hunched appearance and tremor at P22. Gross brain anatomy does not differ between genotypes. C) Survival plots demonstrate 
that incrementally diminishing ganglioside and sulfatide expression corresponds with a reduction in life expectancy up to 25 
weeks. Wild type (n=7) and GalNAc-T-/- (n=10) mice have a normal life expectancy. In the absence of sulfatide with normal 
ganglioside expression life expectancy to 25 weeks is more than halved in CST-/- mice (n=18). Interestingly, in the absence of 
sulfatide and complex gangliosides with the reintroduction of complex gangliosides into neurons alone (n=6), life expectancy is 
improved with 60% of mice surviving to 25 weeks and beyond. Mice with no sulfatide and a-series gangliosides expressed 
globally (n=38) can survive up to 20 weeks. Double ganglioside and sulfatide knock out mice (n=29) have the worst phenotype, 
never surviving past 4 weeks and with death occurring at P21-25. Reintroduction of gangliosides into glial (n=12) does not 
improve survival.  
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Figure 3. The additional loss of complex gangliosides on a sulfatide null background does not augment disorganisation at the 
node of Ranvier or electrophysiological function in the peripheral nervous system. A) There is modest Nav1.6 channel cluster 
lengthening in both CST-/- and CST-/- x GalNAc-T-/- teased sciatic nerve that does not reach significance. Invasion of the sciatic 
nerve paranode by Kv1.1 channels, shown by a decrease in the gap between positive domains, is significantly and comparably 
enhanced in both CST-/- and CST-/- x GalNAc-T-/- mice compared to WT and GalNAc-T-/- nodes of Ranvier. The length of pan-
neurofascin immunostained domains does not significantly differ among genotypes. Representative images are shown of sciatic 
nerve sections from each genotype immunostained for Nav1.6 or anti-Kv1.1 antibody. Nav channel clusters were observed and 
appeared similar in every genotype. Kv1.1 formed two distinct domains of immunostaining at the juxtaparanodes in WT and 
GalNAcT-/- mice. Conversely, mice lacking sulfatide expression had Kv1.1 staining at the paranodes, suggesting disruption to the 
axo-glial junction. (WT n=3,  GalNAc-T-/- n=3, CST-/- n=3, CST-/- x GalNAc-T-/- n=4 Scale bar = 5 µm. B) Perineural recordings of Nav
and Kv channel currents from intercostal nerves showed an increase in recovery time for both peaks following paired pulse 
stimulation in both CST-/- and CST-/- x GalNAc-T-/- mice compared to WT and GalNAc-T-/- mice. The CST-/- and CST-/- x GalNAc-T-/-
mice were not significantly different from each other at any interstimulus interval. Graphs display the means and +SEM for each 
genotype (WT n=5,  GalNAc-T-/- n=2, CST-/- n=3, CST-/- x GalNAc-T-/- n=2), and statistical analysis performed (two-way ANOVA; # 
signifies WT vs. CST-/- x GalNAc-T-/- mice; * signifies WT vs CST-/-; + signifies GalNAc-T-/- vs CST-/- x GalNAc-T-/-; ^ signifies GalNAc-T-
/- vs CST-/- x GalNAc-T-/-). Sciatic nerve conduction velocity decreased in CST-/-(n=4), GalNAc-T-/- (n=4) and CST-/- x GalNAc-T-/-
(n=5) mice compared to wild type (n=3), but only reached significance in CST-/- nerve. C) Peripheral nerve MAG immunostaining 
was comparable among genotypes. Scale bar = 20 µm. Graphs display the means and +SEM for each genotype, ), and statistical 
analysis performed (one-way ANOVA followed by Tukey’s post-hoc tests to compare multiple comparisons, indicated on the 
graphs as follows: *p<0.05; **p<0.01; ***p<0.001).
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Figure 4. Loss of both sulfatide and complex gangliosides results in a modest reduction in CNS Nav channel cluster number and 
sulfatide deficiency reduces NF155 presence at parnodal loops. A) The number of Nav channel clusters significantly decreases in 
glycolipid deficient mouse optic nerves (n=3-4/genotype). Reintroducing a- and b-series gangliosides into neurons rescues this 
feature. B) Nav channel clusters flanked by normal paranodal neurofascin are significantly reduced in number when sulfatide is 
not expressed (n=2-3/genotype). Box-and whisker plots are used to display the spread of all data points collected from each 
animal then means were calculated per genotype for statistical analysis (one-way ANOVA followed by Tukey’s post-hoc tests to 
compare multiple comparisons, indicated on the graphs as follows: *p<0.05; **p<0.01; ***p<0.001). C) Representative images 
of optic nerve sections from each genotype double-immunostained for pan-voltage gated sodium channel (pNav) antibody 
(green) and pan-neurofascin (pNFasc) antibody (red). Na channel clusters were observed in every genotype. pNFasc
immunostaining formed a long band crossing the node and paranodes in WT and GalNAc-T-/- mice suggesting labelling of the 
NF186 and NF155 isoforms, respectively. All of the genotypes lacking sulfatide expression had pNFasc staining restricted to the 
node of Ranvier and co-localising only with pNav staining, suggesting presence of only the NF186 isoform of neurofascin. Scale 
bar = 5 µm.
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Figure 5. Paranodal Caspr dimer immunostaining in CNS tissue is progressively reduced with increasing glycolipid deficiency. A) 
CST-/- x GalNAc-T-/- and CST-/- x GD3s-/- mice have significantly fewer Caspr dimers per field of view (FOV) compared to WT and 
GalNAc-T-/- mice, and are not significantly different to each other (n=2-5/genotype). Caspr dimer number is improved to levels 
within GalNAc-T-/- mice range, but not WT, in CST-/- and CST-/- x GalNAc-T-/--Tg(neuronal) mice, which both display significantly 
more Caspr dimers than CST-/- x GalNAc-T-/- mice. Box-and whisker plots are used to display the spread of all data points 
collected from each animal then means were calculated per genotype for statistical analysis (one-way ANOVA followed by 
Tukey’s post-hoc tests to compare multiple comparisons, indicated on the graphs as follows: *p<0.05; **p<0.01; ***p<0.001).  
B) Representative images of optic nerve sections from each genotype double-immunostained for Caspr (red) and nodal marker 
AnkyrinG (green) show the reduction in Caspr dimer number with diminishing glycolipid expression. Scale bar = 10 µm.
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Figure 6. Glycolipid deficiency reduces CNS axon survival and function. A) Degenerate axon number increases to a significant 
level compared to wild type in optic nerves from CST-/-, CST-/- x GD3s-/- and CST-/- x GalNAc-T-/- mice. Reintroducing a- and b-
series gangliosides into neurons rescues this pathology. B) Electron micrographs depict the differences among the genotypes: 
white arrowheads indicate degenerate axons. Myelin is similar among mouse lines. C) A reduction in conduction velocity was 
observed in optic nerves from CST-/-, CST-/- x GD3s-/- and CST-/- x GalNAc-T-/- mice. There was a reduction in conduction velocity in 
CST-/- x GalNAc-T-/--Tg(neuronal) mice, but this did not reach significance and was improved to within wild type and GalNAc-T-/-
rates. One-way ANOVA followed by Tukey’s post-hoc tests to compare multiple comparisons, indicated on the graphs as follows: 
*p<0.05; **p<0.01; ***p<0.001. Scale bar = 2 µm.
CWild type GalNAcT-/- CST-/-
CST-/- x GalNAcT-/--
Tg(neuronal)
CST-/- x GalNAcT-/-CST-/- x GD3s-/-
***
***
*
*
**
***
A Degenerate axon density
(Optic nerve)
A
xo
n
/m
m
2
C V  to  h ig h e s t  p e a k
T
im
e
 (
s
)
W
T
G
M
2
k
o
C
S
T
k
o
C
S
T
 T
h
y
1
C
S
T
G
D
3
C
S
T
G
M
2
0 .0
0 .5
1 .0
1 .5
2 .0
2 .5
Ch.0 
    -1 mV 
1.638 ms
Ch.0 
    -1 mV 
1.638 ms
Ch.0 
    -1 mV 
1.638 ms
Ch.0 
    -1 mV 
1.638 ms
Ch.0 
    -1 mV 
1.638 ms
Ch.0 
    -1 mV 
1.638 ms
Wild type GalNAcT-/- CST-/-
CST-/- x GalNAcT-/--
Tg(neuronal)
CST-/- x GalNAcT-/-CST-/- x GD3s-/-
CV to highest peak
(Optic nerve)
m
/s
Figure 6. Glycolipid deficiency reduces CNS axon survival and function. A) Degenerate axon number increases to a significant 
level compared to wild type in optic nerves from CST-/-, CST-/- x GD3s-/- and CST-/- x GalNAc-T-/- mice. Reintroducing a- and b-
series gangliosides into neurons rescues this pathology. B) Electron micrographs depict the differences among the genotypes: 
white arrowheads indicate degenerate axons. Myelin is similar among mouse lines. Scale bar = 2 µm C) A reduction in 
conduction velocity was observed in optic nerves with diminishing glycolipid content. Representative CAP traces from each 
genotype show the normal waveform in WT, GalNAc-T-/- and CST-/- x GalNAc-T-/--Tg(neuronal) optic nerves, however the 
waveform becomes abnormal in the CST-/-, CST-/- x GD3s-/- and CST-/- x GalNAc-T-/- mice. One-way ANOVA followed by Tukey’s 
post-hoc tests to compare multiple comparisons, indicated on the graphs as follows: *p<0.05; **p<0.01; ***p<0.001. Horizontal 
scale bar = 2 ms, vertical scale bar = 1 mV.
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Figure 7. N.B. New order of 
genotypes. MAG and NF155 
expression in the myelin 
fraction is altered by 
glycolipid deficiency. A) In 
the myelin fraction from P22 
brain homogenates 
(n=4/genotype), MAG is 
significantly reduced in CST-/-
x GalNAc-T-/- mice compared 
to all genotypes, which do 
not significantly differ from 
one another (upper graph). 
All genotypes have a 
significant reduction in MAG 
expression in whole brain 
homogenate compared to 
WT (middle graph). Myelin 
NF155 was significantly 
reduced in all genotypes 
compared to WT (indicated 
by *) and GalNAc-T-/-
(indicated by #), which had 
similar levels (lower graph). 
^indicates significant 
difference between CST-/- x 
GalNAc-T-/- and CST-/- x 
GalNAc-T-/--Tg(neuronal) 
mice. Olig2 is unchanged by 
altered glycolipid expression. 
Representative blots show 
protein intensity per 
genotype, indicated by the 
corresponding number 
indicated in the key. B) P22 
optic nerve MAG 
immunostaining 
(n=3/genotype) is 
significantly reduced in all 
genotypes compared to wild 
type nerve, which do not 
significantly differ from one 
another. Representative 
images show MAG 
immunostaining per 
genotype. Means were 
calculated per genotype for 
statistical analysis (one-way 
ANOVA followed by Tukey’s 
post-hoc tests to compare 
multiple comparisons, 
indicated on the graphs as 
follows: *p<0.05; **p<0.01; 
***p<0.001). Scale bar = 50 
µm. 
           O lig 2  1 0 u g  to ta l b ra in  h o m o g e n a te
W
T
G
M
2
C
S
T
G
M
2
/C
S
T
G
D
3
/C
S
T
G
M
2
/C
S
T
/T
h
y
1
0
5 0 0 0
1 0 0 0 0
1 5 0 0 0
2 0 0 0 0
2 5 0 0 0
P 2 2
In
te
n
s
it
y
 o
f 
b
a
n
d
Total brain: Olig2
A
rb
it
ra
ry
 in
te
n
si
ty
38 kDa
26 kDa 1         2         3        4         5         6  
Total: Olig2
Contactin
Caspr
Nf155
Paranodal
loop
Sulfatide
raft
ganglioside
raft
MAG
Axonal cytoplasm
Wild type GalNAcT -/- CST-/-
CST-/- x GalNAcT-/-
-Tg(neuronal)
CST-/- x GD3s-/- CST-/- x GalNAcT-/-
a-series
raft
GD1a
GT1b
Figure 8. Schematic depicting the glycolipid rafts and changes to their associated paranodal proteins Caspr, NF155 and MAG 
composition in our transgenic mouse lines. GD1a and GT1b are represented in the ganglioside rafts as they are the major ligands 
of MAG, however, in reality the rafts would contain all complex gangliosides. Normally GD1a and GT1b in rafts will tether MAG
but in their absence MAG does not make the axo-glial connection. If NF155 is present, this protein can partner with 
Caspr/Contactin to make an axo-glial junction. However, when sulfatide is absent, NF155 is also lost from the paranode.  In the 
absence of NF155, Caspr presence is also diminished, especially with loss of complex ganglioside rafts. Under both ganglioside 
and sulfatide raft deficiency, we propose that MAG and NF155 are both absent from the paranodal axo-glial domain.
